Back to Search Start Over

RT-RPA- Pf Ago detection platform for one-tube simultaneous typing diagnosis of human respiratory syncytial virus.

Authors :
Liao JY
Feng XY
Zhang JX
Yang TD
Zhan MX
Zeng YM
Huang WY
Lian HB
Ke L
Cai SS
Zhang NF
Fang JW
Cai XY
Chen JD
Lin GY
Lin LY
Chen WZ
Liu YY
Huang FF
Lin CX
Lin M
Source :
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Jul 25; Vol. 14, pp. 1419949. Date of Electronic Publication: 2024 Jul 25 (Print Publication: 2024).
Publication Year :
2024

Abstract

Human respiratory syncytial virus (HRSV) is the most prevalent pathogen contributing to acute respiratory tract infections (ARTI) in infants and young children and can lead to significant financial and medical costs. Here, we developed a simultaneous, dual-gene and ultrasensitive detection system for typing HRSV within 60 minutes that needs only minimum laboratory support. Briefly, multiplex integrating reverse transcription-recombinase polymerase amplification (RT-RPA) was performed with viral RNA extracted from nasopharyngeal swabs as a template for the amplification of the specific regions of subtypes A (HRSV <subscript>A</subscript> ) and B (HRSV <subscript>B</subscript> ) of HRSV. Next, the Pyrococcus furiosus Argonaute ( PfAgo ) protein utilizes small 5'-phosphorylated DNA guides to cleave target sequences and produce fluorophore signals (FAM and ROX). Compared with the traditional gold standard (RT-qPCR) and direct immunofluorescence assay (DFA), this method has the additional advantages of easy operation, efficiency and sensitivity, with a limit of detection (LOD) of 1 copy/μL. In terms of clinical sample validation, the diagnostic accuracy of the method for determining the HRSV <subscript>A</subscript> and HRSV <subscript>B</subscript> infection was greater than 95%. This technique provides a reliable point-of-care (POC) testing for the diagnosis of HRSV-induced ARTI in children and for outbreak management, especially in resource-limited settings.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Liao, Feng, Zhang, Yang, Zhan, Zeng, Huang, Lian, Ke, Cai, Zhang, Fang, Cai, Chen, Lin, Lin, Chen, Liu, Huang, Lin and Lin.)

Details

Language :
English
ISSN :
2235-2988
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in cellular and infection microbiology
Publication Type :
Academic Journal
Accession number :
39119294
Full Text :
https://doi.org/10.3389/fcimb.2024.1419949